We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement

A Potential Drug Target To Slow Lymphoma Tumor Growth

News   Apr 08, 2020 | Original story from Max Delbrück Center for Molecular Medicine in the Helmholtz Association (MDC)

 
A Potential Drug Target To Slow Lymphoma Tumor Growth

Left, lymph node from a non-lymphoma bearing control mouse. Right, vascular tree in lyph nodes from a lymphoma-bearing mouse. Credit: Rehm, Höpken, Gerhardt Labs, MDC

 
 
Advertisement
 

RELATED ARTICLES

Testing Patients for Endothelial Cell Injury Could Help To Predict COVID-19 Severity

News

Researchers at Yale have found that injury to endothelial cells may be a key driver of COVID-19 severity and death. The discovery suggests that doctors could both test patients for endothelial cell injury, known as endotheliopathy, and mitigate it with drugs to improve patient outcomes.

READ MORE

SARS-CoV-2 Can Infect Heart Cells in a Lab Dish

News

A new study shows that SARS-CoV-2, the virus that causes COVID-19, can infect heart cells in a lab dish, indicating it may be possible for heart cells in COVID-19 patients to be directly infected by the virus.

READ MORE

Findings From "Mini-brain" Study Suggest SARS-CoV-2 Can Infect Human Brain Cells

News

A multidisciplinary team from two Johns Hopkins University institutions has found that organoids (tiny tissue cultures made from human cells that simulate whole organs) known as "mini-brains" can be infected by the SARS-CoV-2 virus that causes COVID-19.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Cancer Research Cell Science Drug Discovery

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE